Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here are three cash-producing companies to steer clear of and a few better alternatives. Zoom (ZM) Trailing 12-Month Free Cash Flow Margin: 38.8% Started by Eric Yuan who once ran engineering for Cisco’s video conferencing business, Zoom (NASDAQ:ZM) offers an easy to use, cloud-based platform for video conferencing, audio conferencing and screen sharing. Why Does ZM Fall Short? ARR growth averaged a weak 3.1% over the last year, suggesting that competition is pulling some attention away from its software Estimated sales growth of 2.5% for the next 12 months implies demand will slow from its three-year trend Capital intensity will likely increase as its free cash flow margin is anticipated to drop by 5 percentage points over the next year At $73.59 per share, Zoom trades at 4.8x forward price-to-sales. To fully understand why you should be careful with ZM, check out our full research report (it’s free). AdaptHealth (AHCO) Trailing 12-Month Free Cash Flow Margin: 7.2% With a network of approximately 680 locations serving patients across all 50 states, AdaptHealth (NASDAQ:AHCO) provides home medical equipment, supplies, and related services to patients with chronic conditions like sleep apnea, diabetes, and respiratory disorders. Why Does AHCO Worry Us? Sales trends were unexciting over the last two years as its 4.8% annual growth was below the typical healthcare company ROIC of 2.4% reflects management’s challenges in identifying attractive investment opportunities, and its decreasing returns suggest its historical profit centers are aging AdaptHealth’s stock price of $7.82 implies a valuation ratio of 7.5x forward price-to-earnings. If you’re considering AHCO for your portfolio, see our FREE research report to learn more. Connection (CNXN) Trailing 12-Month Free Cash Flow Margin: 5.9% Starting as a small computer products seller in 1982 and evolving into a Fortune 1000 company, Connection (NASDAQ:CNXN) is a technology solutions provider that helps businesses and government agencies design, purchase, implement, and manage their IT infrastructure and systems. Why Should You Dump CNXN? Products and services are facing significant end-market challenges during this cycle as sales have declined by 5.3% annually over the last two years Falling earnings per share over the last two years has some investors worried as stock prices ultimately follow EPS over the long term Low free cash flow margin of 3.2% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders Story Continues Connection is trading at $60.40 per share, or 16.9x forward price-to-earnings. Dive into our free research report to see why there are better opportunities than CNXN. Stocks We Like More Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Axon (+711% five-year return). Find your next big winner with StockStory today for free. View Comments
3 Cash-Producing Stocks That Concern Us
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...